Liver Transplantation

Treatment for Liver cancer due to hepatitis B

Typical Dosage: procedure-based, immunosuppressants lifelong

Effectiveness
95%
Safety Score
25%
Clinical Trials
50
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
procedure-based, immunosuppressants lifelong
Time to Effect
immediate (tumor removal), long-term survival benefit
Treatment Duration
single surgery, lifelong immunosuppression
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$15,000
Side Effect Mgmt:$10,000
Total Annual:$40,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
MODERATE
ICER
$150,000/QALY
QALYs Gained
8
Comparison vs Surgical Resection
Cost Difference
+$200,000/year
More expensive
QALY Difference
+1.00 QALYs
Better outcomes
Dominance
No dominance
Liver Transplantation Outcomes

for Liver cancer due to hepatitis B

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+100%
Remission Rate
+100%
Common Side Effects
Surgical complications (bleeding, infection)
+15%
Organ rejection
+20%
Kidney dysfunction (due to immunosuppressants)
+30%
Increased infection risk
+40%
New-onset diabetes
+10%

Sources:

semanticscholar.org
nih.gov
amegroups.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov